Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2016
Opticyte is a medical device innovator focused on transforming the standard of care for sepsis and organ failure through its proprietary Vital O₂ device, which provides real-time measurements of cellular oxygen levels. This technology addresses significant healthcare disparities, particularly for people of color, by offering accurate diagnostics that current pulse oximeters fail to deliver. Recognized by the FDA as a Breakthrough Device, Opticyte aims to commercialize its solution rapidly, leveraging machine learning and clinical data to improve patient outcomes. Founded in 2016 and backed by substantial non-dilutive funding, Opticyte is positioned to lead in a $3 billion global market opportunity, targeting emergency departments and intensive care units.
Something looks off?